Literature DB >> 28877547

Comparing excitability at 37°C versus at 20°C: Differences between motor and sensory axons.

Maria O Kovalchuk1, Hessel Franssen1, Leonard J Van Schelven2, Boudewijn T H M Sleutjes1.   

Abstract

INTRODUCTION: In some peripheral nervous system disorders, cold induces symptoms of muscle weakness without loss of sensation. To understand this selective effect on motor function, it is first essential to delineate the effects of cooling in motor and sensory axons of healthy subjects.
METHODS: In 17 healthy volunteers, we performed excitability and clinical tests of median nerve motor and sensory axons at 37°C and at 20°C. Clinical tests consisted of assessing thenar muscle strength, 2-point discrimination, and joint position sense of the third finger.
RESULTS: Excitability tests showed that cooling induced opposite changes to hyperpolarizing current in threshold electrotonus (motor, decreased threshold change; sensory, increased threshold change) and current-voltage relation slopes (motor, steepening; sensory, less steep). Clinical tests showed worsening in motor function but no consistent changes in sensory function. DISCUSSION: Cooling induces changes in motor axons consistent with depolarization and more complicated changes in sensory axons, possibly related to differences in hyperpolarization-activated cyclic nucleotide-gated channel expression. Muscle Nerve 57: 574-580, 2018.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  HCN-channels; axon; conduction block; excitability; multifocal motor neuropathy; temperature

Mesh:

Year:  2017        PMID: 28877547     DOI: 10.1002/mus.25960

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  1 in total

1.  Cold aggravates abnormal excitability of motor axons in oxaliplatin-treated patients.

Authors:  Kristine Bennedsgaard; Lise Ventzel; Peter Grafe; Jenny Tigerholm; Andreas C Themistocleous; David L Bennett; Hatice Tankisi; Nanna B Finnerup
Journal:  Muscle Nerve       Date:  2020-03-20       Impact factor: 3.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.